Review Article
Management of the Bleeding Patient Receiving New Oral Anticoagulants: A Role for Prothrombin Complex Concentrates
Table 1
Prothrombin complex concentrates (PCC) available in the United States.
| Product | Coagulation factors in product | FDA approved indications to manage hemorrhage | Heparin in product? |
| Nonactivated | | | | 3-factor PCC | | | | Profilnine | Nonactivated II, IX, X, and small amounts of VII | Hemophilia B | No | Bebulin | Nonactivated II, IX, X, and small amounts of VII | Hemophilia B | Yes | 4-factor PCC | | | | Kcentra | Nonactivated II, VII, IX, X, protein C, and protein S | Warfarin | Yes | Activated PCC | | | | Feiba | Activated VII, nonactivated II, IX, and X | Hemophilia A & B with inhibitors | No |
|
|